Serum Osteopontin Enhances Hepatocellular Carcinoma Diagnosis and Predicts Anti-PD-L1 Immunotherapy Benefit.
血清骨桥蛋白可提高肝细胞癌的诊断率并预测抗PD-L1免疫疗法的疗效
期刊:Journal of Hepatocellular Carcinoma
影响因子:3.4
doi:10.2147/JHC.S514144
Wu Miantao, Zou Fei, He Suyin, Pi Yingqi, Song Yiling, Chen Shulin, Li Linfang
